ASCO 2026: Comment: Multi-cancer earlier detection tests

Velzatinib demonstrates broad activity across KIT mutations in advanced gastrointestinal stromal tumours

Optimal panitumumab–bevacizumab sequencing evaluated in RAS wild-type metastatic colorectal cancer

Short-term fasting linked to improved chemo response in advanced ovarian cancer

MCED blood test trial fails primary end point, but screening cut number of cancers found at stage IV

miR371 shows promise as a surveillance biomarker for relapse in early-stage germ cell tumours

Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer

Abemaciclib shows benefit in dedifferentiated liposarcoma

Adjuvant selpercatinib reduces recurrence in RET-positive lung cancer

ASCO 2026: Latest updates in mRCC

Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma

Part 1: Why test?